Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008
The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. T...
Saved in:
Main Author: | |
---|---|
Format: | text |
Published: |
Animo Repository
2012
|
Subjects: | |
Online Access: | https://animorepository.dlsu.edu.ph/faculty_research/6716 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | De La Salle University |
id |
oai:animorepository.dlsu.edu.ph:faculty_research-7505 |
---|---|
record_format |
eprints |
spelling |
oai:animorepository.dlsu.edu.ph:faculty_research-75052022-09-10T05:32:08Z Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 Lim, Cristina Teresa N. The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. These include pharmaceutical companies, pharmacists, cardiologists, internal medicine specialists, and out-patients from charity wards of selected public and private hospitals and drugstores were interviewed. Results of the study showed that after two years of the implementation of the Act, medicines are still expensive and branded medicines are still dispensed, prescribed and purchased more than medicines. Stakeholders have low level of perception of the Act resulting to non-compliance. They also believed that the Act is not strong enough to enforce generic prescription while patients are apprehensive of the effectiveness of generic medicines. Pharmaceutical companies experienced a decreased in the production output, thus, pharmaceutical companies were not encouraged to manufacture and offer for sale generic medicines. 2012-07-29T07:00:00Z text https://animorepository.dlsu.edu.ph/faculty_research/6716 Faculty Research Work Animo Repository Drugs—Prices—Law and legislation—Philippines Drugs—Generic substitution—Law and legislation—Philippines Philippines. Universally Accessible Cheaper Medicines Act of 2008 Medical Jurisprudence |
institution |
De La Salle University |
building |
De La Salle University Library |
continent |
Asia |
country |
Philippines Philippines |
content_provider |
De La Salle University Library |
collection |
DLSU Institutional Repository |
topic |
Drugs—Prices—Law and legislation—Philippines Drugs—Generic substitution—Law and legislation—Philippines Philippines. Universally Accessible Cheaper Medicines Act of 2008 Medical Jurisprudence |
spellingShingle |
Drugs—Prices—Law and legislation—Philippines Drugs—Generic substitution—Law and legislation—Philippines Philippines. Universally Accessible Cheaper Medicines Act of 2008 Medical Jurisprudence Lim, Cristina Teresa N. Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
description |
The study aimed to assess if Republic Act No. 9502, otherwise known as Cheaper Medicines Act of 2008 has been adequately implemented in making cardiovascular medicines accessible and affordable in the Philippines. Sample respondents from the City of Manila, Makati City and Quezon were interviewed. These include pharmaceutical companies, pharmacists, cardiologists, internal medicine specialists, and out-patients from charity wards of selected public and private hospitals and drugstores were interviewed. Results of the study showed that after two years of the implementation of the Act, medicines are still expensive and branded medicines are still dispensed, prescribed and purchased more than medicines. Stakeholders have low level of perception of the Act resulting to non-compliance. They also believed that the Act is not strong enough to enforce generic prescription while patients are apprehensive of the effectiveness of generic medicines. Pharmaceutical companies experienced a decreased in the production output, thus, pharmaceutical companies were not encouraged to manufacture and offer for sale generic medicines. |
format |
text |
author |
Lim, Cristina Teresa N. |
author_facet |
Lim, Cristina Teresa N. |
author_sort |
Lim, Cristina Teresa N. |
title |
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
title_short |
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
title_full |
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
title_fullStr |
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
title_full_unstemmed |
Pharmaceuticals law management: Assessment of feasibility and effectiveness of the Universally Accessible Cheaper Medicines Act of 2008 |
title_sort |
pharmaceuticals law management: assessment of feasibility and effectiveness of the universally accessible cheaper medicines act of 2008 |
publisher |
Animo Repository |
publishDate |
2012 |
url |
https://animorepository.dlsu.edu.ph/faculty_research/6716 |
_version_ |
1767196596784594944 |